Table 7.
Rank | Frequency | Keyword | Centrality |
---|---|---|---|
1 | 2503 | Postherpetic neuralgia | 0.02 |
2 | 1132 | Neuropathic pain | 0.09 |
3 | 1015 | Herpes zoster | 0.02 |
4 | 960 | Double blind | 0.7 |
5 | 457 | Efficacy | 0.25 |
6 | 410 | Pain | 0.17 |
7 | 398 | Management | 0 |
8 | 335 | Quality of life | 0.07 |
9 | 279 | Gabapentin | 0.4 |
10 | 279 | Diabetic neuropathy | 0.21 |
11 | 274 | Epidemiology | 0.29 |
12 | 234 | Placebo controlled trial | 0.68 |
13 | 221 | Risk factors | 0.2 |
14 | 203 | Randomized controlled trial | 0.86 |
15 | 200 | Diabetic peripheral neuropathy | 0.64 |
16 | 182 | Chronic pain | 0 |
17 | 163 | Trigeminal neuralgia | 0.13 |
18 | 157 | Impact | 0.11 |
19 | 152 | Therapy | 0.31 |
20 | 147 | Safety | 0.17 |
PHN = postherpetic neuralgia